Filing Details
Senti Biosciences Holdings, Inc. (NASDAQ:SNTI) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event.
8k filedNASDAQ:SNTI
Senti Biosciences Holdings, Inc. (SNTI) Reports Material Event to SEC
Filing Details Senti Biosciences Holdings, Inc. (NASDAQ:SNTI) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event. Market…
Market Context
Senti Biosciences Holdings, Inc.'s stock currently trades at $0.58 with a market capitalization of $37.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Senti Biosciences Holdings, Inc.'s stock.
All SEC filings for Senti Biosciences Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SNTI Stock Page
Frequently Asked Questions
Where can I read SNTI's SEC filings?
Browse all filings on our SNTI SEC filings page.
What types of SEC filings does Senti Biosciences Holdings, Inc. file?
Public companies like Senti Biosciences Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.